Skip to content

A multicenter randomized controlled clinical trial based on Yang Jiebin's classic acupuncture therapy "Acupuncture Blood Cupping" for the treatment of low back and leg pain

A multicenter randomized controlled clinical trial based on Yang Jiebin's classic acupuncture therapy "Acupuncture Blood Cupping" for the treatment of low back and leg pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000084
Enrollment
Unknown
Registered
2025-01-13
Start date
2021-07-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation and lumbar spinal stenosis

Interventions

Control group:Conventional acupuncture plus moxibustion
Intervention group:Yang Jiebin's classic acupuncture method plus blood cupping and moxibustion

Sponsors

The Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for lumbar disc herniation and lumbar spinal stenosis; (2) Aged 18-65 years old; (3) Patients can express their own wishes and have at least elementary school education or above (with certain reading and comprehension skills); (4) Have stable vital signs, clear consciousness, no critical illness, and can cooperate with treatment; (5) Voluntarily participate, agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with concurrent diseases such as lumbar fracture, lumbar hemangioma, tuberculosis infection of lumbar vertebrae, malignant tumors, etc.; (2) Patients with concurrent diseases such as severe cognitive dysfunction or severe aphasia, as well as other patients who may affect the authenticity of filling out the form; (3) Patients with concurrent diseases such as severe heart, liver, kidney or mental illness; (4) Women who are breastfeeding, pregnant or preparing for pregnancy; (5) Patients with contraindications to acupuncture, such as thrombocytopenia, hemophilia and other coagulation disorders; (6) Patients who are undergoing other clinical trials in addition to this study.

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Secondary

MeasureTime frame
SF-36 quality of life assessment scale;Patient Reported Outcome scale;JOA score;

Countries

China

Contacts

Public ContactHong Zhang

Chengdu University of Traditional Chinese Medicine

hzhang0123@foxmail.com13308199375

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026